Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

14.84USD
23 Jan 2015
Change (% chg)

$-0.09 (-0.60%)
Prev Close
$14.93
Open
$14.86
Day's High
$15.01
Day's Low
$14.74
Volume
2,698,042
Avg. Vol
2,814,262
52-wk High
$15.01
52-wk Low
$11.11

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions,... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $19,685.11
Shares Outstanding(Mil.): 1,326.49
Dividend: --
Yield (%): --

Financials

Search Stocks

J&J's $7.2 bln claim against Boston Scientific now with U.S. judge

NEW YORK, Jan 21 - For more than eight years, Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial - and ultimately ill-fated - bidding war for device maker Guidant.

22 Jan 2015

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters Jan 6, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, now click on Related Co Data, now click on Co Events.

06 Jan 2015

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters Jan 5, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, now click on Related Co Data, now click on Co Events.

05 Jan 2015

Transvaginal mesh trial losses put pressure on Boston Scientific

NEW YORK - Boston Scientific Corp’s back-to-back losses in the first two federal trials over its transvaginal mesh devices could drive up the cost of resolving thousands of similar lawsuits, according to legal experts.

22 Nov 2014

Boston Scientific to pay $18.5 million in mesh case

NEW YORK - Boston Scientific Corp was ordered Thursday to pay $18.5 million for injuries caused by transvaginal mesh devices, a plaintiffs’ lawyer said, in the third courtroom loss for the company over the products.

21 Nov 2014

UPDATE 2-Boston Scientific to pay $18.5 mln in mesh case

NEW YORK, Nov 20 - Boston Scientific Corp was ordered Thursday to pay $18.5 million for injuries caused by transvaginal mesh devices, a plaintiffs' lawyer said, in the third courtroom loss for the company over the products.

21 Nov 2014

J&J demands $7.2 billion from Boston Scientific as trial begins

NEW YORK - Boston Scientific Corp should pay Johnson & Johnson $7.23 billion in damages and interest for breach of contract, nearly nine years after Boston Scientific won a controversial bidding war for device maker Guidant, lawyers for J&J told a U.S. federal judge on Thursday.

20 Nov 2014

J&J demands $7.2 bln from Boston Scientific as trial begins

NEW YORK, Nov 20 - Boston Scientific Corp should pay Johnson & Johnson $7.23 billion in damages and interest for breach of contract, nearly nine years after Boston Scientific won a controversial bidding war for device maker Guidant, lawyers for J&J told a U.S. federal judge on Thursday.

20 Nov 2014

Boston Scientific ordered to pay $14.5 mln for transvaginal mesh injuries

NEW YORK, Nov 20 - Boston Scientific Corp was ordered Thursday to pay $14.5 million for injuries caused by transvaginal mesh devices and may face millions of dollars in additional damages, in the third courtroom loss for the company over the devices, a plaintiffs' lawyer said.

20 Nov 2014

Boston Scientific stent succeeds in study aimed at U.S. approval

CHICAGO, Nov 19 - Boston Scientific Corp's next generation Synergy heart stent succeeded in a pivotal study that will be used to seek U.S. and Japanese approval of the device, according to data presented at the American Heart Association meeting in Chicago on Wednesday.

19 Nov 2014

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $43.86 -0.63
Medtronic, Inc. (MDT.N) $76.95 +1.47
St. Jude Medical, Inc. (STJ.N) $64.99 -1.69

Earnings vs. Estimates

Search Stocks